Study Records. In the event the Company believes in good faith that the Group has materially failed to comply with applicable laws, or in the event required by regulatory authorities, or to defend any claim or action against the Company, Study records (other than those to be provided in accordance with the Agreement) shall be made reasonably available to the Company for inspection during normal business hours; provided however, that (1) the records may be located at individual Member Institutions; (2) access to the records will be subject to the respective operating procedures of the individual institutions; and (3) the Company may be required to reimburse the Group and/or Member Institutions for reasonable time cost and expense (which may include without limitation, staffing and internal costs and expense) necessary to provide such access.
Appears in 3 contracts
Sources: Clinical Trial Agreement (Syndax Pharmaceuticals Inc), Clinical Trial Agreement (Syndax Pharmaceuticals Inc), Clinical Trial Agreement (Syndax Pharmaceuticals Inc)